DOPTELET 20 mg (avatrombopag)
Unfavourable opinion for reimbursement in the treatment of primary chronic immune thrombocytopenia (ITP) in adult patients who are refractory to other treatments. Role in the care pathway? In France, the treatment of primary immune thrombocytopenia (ITP) (or idiopathic thrombocytopenic purpura) is based primarily on the French national diagnost